A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer
Clinical trial NCT03989336 · COMPLETED
Trial details
- NCT number
- NCT03989336
- Sponsor
- Chinese PLA General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-23
- Primary completion
- 2022-05-22
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.